Anika Therapeutics SG&A Expense (TTM) Analysis | YCharts

Anika Therapeutics, Inc. (ANIK)

20.81 -0.19 (-0.90%) USD | NASDAQ | Sep 04, 16:00

20.82 +0.02 (+0.07%) After-Hours: 20:00

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for ANIK.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View SG&A Expense (TTM) Chart

Start Trial

Historical SG&A Expense (TTM) Data

View and export this data back to 1998. Start Trial.

Date	Value
June 30, 2026	52.67M
March 31, 2026	53.95M
December 31, 2025	49.09M
September 30, 2025	48.33M
June 30, 2025	55.57M
March 31, 2025	63.15M
December 31, 2024	71.77M
September 30, 2024	80.78M
June 30, 2024	86.50M
March 31, 2024	90.38M
December 31, 2023	95.85M
September 30, 2023	98.56M
June 30, 2023	95.01M
March 31, 2023	92.59M
December 31, 2022	84.79M
September 30, 2022	82.18M
June 30, 2022	78.40M
March 31, 2022	75.12M
December 31, 2021	74.10M
September 30, 2021	68.84M
June 30, 2021	67.25M
March 31, 2021	63.81M
December 31, 2020	60.06M
September 30, 2020	57.12M
June 30, 2020	48.76M

Date	Value
March 31, 2020	41.71M
December 31, 2019	34.95M
September 30, 2019	28.84M
June 30, 2019	27.00M
March 31, 2019	25.92M
December 31, 2018	34.34M
September 30, 2018	34.88M
June 30, 2018	34.01M
March 31, 2018	32.56M
December 31, 2017	21.54M
September 30, 2017	20.35M
June 30, 2017	19.81M
March 31, 2017	19.09M
December 31, 2016	18.01M
September 30, 2016	17.05M
June 30, 2016	16.08M
March 31, 2016	15.21M
December 31, 2015	14.83M
September 30, 2015	13.97M
June 30, 2015	14.71M
March 31, 2015	15.19M
December 31, 2014	15.07M
September 30, 2014	13.80M
June 30, 2014	12.95M
March 31, 2014	12.48M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years

Start Trial

--

Minimum

--

Maximum

--

Average

--

Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks

Start Trial

Perspective Therapeutics, Inc.	29.46M
MiMedx Group, Inc.	255.08M
ABVC BioPharma, Inc.	6.400M
Intuitive Surgical, Inc.	2.492B
Enovis Corp.	1.081B